Liquid Biopsy Market with COVID-19 Impact Analysis, By Sample, By Biomarker (Circulating Nucleic Acids, CTC, Exosomes/Microvesicles, and Circulating Proteins), By Technology, By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
The Liquid Biopsy Market size was valued at USD 4,404.7 Million in 2022, expanding at a CAGR of 20.1% from 2023 to 2030.
Liquid biopsy is a minimally invasive alternative to surgical biopsies that enables medical professionals to learn more about a tumor from a blood sample and customize the therapy accordingly. It can give a solid foundation for customized therapy and reflect changes in the gene expression profile of the tumor. Early diagnostic screening, tumor heterogeneity, and medication resistance are all aided by it. In addition to this, it also finds EGFR gene mutations, which are common in non-small cell lung cancer patients (NSCLC).
Liquid Biopsy Market- Market Dynamics
The number of cancer patients worldwide is growing as a result of sedentary lifestyles and increased cigarette use. One of the primary factors influencing the market is the rising knowledge among people about sophisticated minimally invasive (MI) techniques in cancer diagnoses. Furthermore, to promote the introduction of cutting-edge cancer treatments, the governments of numerous nations are funding research and development (R&D) projects. These institutions also make large investments in the growth of the healthcare sector, which provides key competitors in the market with attractive chances for expansion.
In addition, major market participants are concentrating on product introductions to expand customized medicine globally. To improve the workflow and results of the liquid biopsy method, they are also incorporating technological developments. This is helping to drive the industry along with the increasing use of blood-based biopsy diagnostics for early tumor identification. The need for liquid biopsy is also being fueled by the growing use of exosomes for clinical diagnosis of cancer due to their high accuracy and quick turnaround times. Rapid advancements in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) technology are expected to drive the market's expansion.
Liquid Biopsy Market- Segmentation Analysis:
Based on the sample, blood sample-based tests are expected to dominate the market during the forecast period. A blood test is non-invasive, risk-free, and painless. Additionally, it decreases the expense and length of the diagnostic process. The detection of CTCs, cfDNAs, exosomes, and microvesicles in the blood sample has increased the use of blood-based liquid biopsy. Moreover, Understanding carcinogenesis and metastasis are largely dependent on the circulating biomarkers in blood, which may also be used to predict tumor dynamics throughout therapy and disease progression. Additionally, the market is anticipated to be driven by increasing research on blood-based cancer testing. For instance, a research team at Exact Sciences and UW-Madison began developing liquid biopsies for cancer in August 2021. One of these liquid biopsies is a blood test that can assist identify genetic abnormalities in tumors that are the focus of medication treatments. This test aids in the early diagnosis of the disease and can identify cancer recurrence following therapy.
Based on the technology, the Multi-gene-parallel Analysis (NGS) segment is expected to hold the largest market share during the forecast period. NGS technology may identify a wide range of mutations that can contribute to carcinogenesis as well as identify potential resistance mechanisms that might have emerged from pre-existing clones following therapy. Recent fast advancements in NGS technology have resulted in a considerable cost decrease for high-accuracy sequencing. This approach enables the screening of unidentified variations and is employed in focused panels for the precise and extremely sensitive identification of ctDNA mutations. For instance, 59% of patients with stage 1 or stage 2 lung cancer may be found using NGS with a MAF of 0.1%.
Liquid Biopsy Market- Geographical Insights
North America is expected to dominate the market during the forecast period. Due to higher investments and the existence of several biotechnology businesses producing the tests, the U.S. dominates the regional market. Liquid biopsy is supported by several organizations, including the American Society of Clinical Oncology (ASCO). In consequence, it is projected that this would accelerate market expansion in this region. Since tests that have received FDA approval may be utilized there, Canada has followed the United States in adopting liquid biopsy procedures. Additionally, the industry is highly competitive, which is anticipated to fuel market expansion throughout the forecast period. The government's increased grants and investments in the development of liquid biopsy tests are anticipated to raise demand in the nation.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LIQUID BIOPSY MARKET KEY PLAYERS
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- BIOCEPT, Inc.
- Guardant Health, Inc.
- QIAGEN
- Illumina, Inc.
- Angle plc
- Oncimmune
- Myriad Genetics, Inc.
- Lucence health Inc.
- EPIGENOMICS AG
- FreenomeHoldings, Inc.
GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE
- Blood Sample-based
- Others
GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER
- Circulating Nucleic Acids
- CTC
- Exosomes/Microvesicles
- Circulating Proteins
GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY
- Multi-gene-parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
GLOBAL LIQUID BIOPSY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Liquid Biopsy Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Liquid Biopsy Market Snippet by Sample
2.1.2. Liquid Biopsy Market Snippet by Biomarker
2.1.3. Liquid Biopsy Market Snippet by Technology
2.1.4. Liquid Biopsy Market Snippet by Country
2.1.5. Liquid Biopsy Market Snippet by Region
2.2. Competitive Insights
3. Liquid Biopsy Key Market Trends
3.1. Liquid Biopsy Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Liquid Biopsy Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Liquid Biopsy Market Opportunities
3.4. Liquid Biopsy Market Future Trends
4. Liquid Biopsy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Liquid Biopsy Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Liquid Biopsy Market Landscape
6.1. Liquid Biopsy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Liquid Biopsy Market – By Sample
7.1. Overview
7.1.1. Segment Share Analysis, By Sample, 2022 & 2030 (%)
7.1.2. Blood Sample-based
7.1.3. Others
8. Liquid Biopsy Market – By Biomarker
8.1. Overview
8.1.1. Segment Share Analysis, By Biomarker, 2022 & 2030 (%)
8.1.2. Circulating Nucleic Acids
8.1.3. CTC
8.1.4. Exosomes/Microvesicles
8.1.5. Circulating Proteins
9. Liquid Biopsy Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
9.1.2. Multi-gene-parallel Analysis (NGS)
9.1.3. Single Gene Analysis (PCR Microarrays)
10. Liquid Biopsy Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Liquid Biopsy Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Liquid Biopsy Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Liquid Biopsy Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Liquid Biopsy Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Liquid Biopsy Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Sample, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Biomarker, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Liquid Biopsy Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.2. Thermo Fisher Scientific, Inc.
11.2.3. BIOCEPT, Inc.
11.2.4. Guardant Health, Inc.
11.2.5. QIAGEN
11.2.6. Illumina, Inc.
11.2.7. Angle plc
11.2.8. Oncimmune
11.2.9. Myriad Genetics, Inc.
11.2.10. Lucence health Inc.
11.2.11. EPIGENOMICS AG
11.2.12. FreenomeHoldings, Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
